EE200000638A - 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm - Google Patents

1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm

Info

Publication number
EE200000638A
EE200000638A EEP200000638A EEP200000638A EE200000638A EE 200000638 A EE200000638 A EE 200000638A EE P200000638 A EEP200000638 A EE P200000638A EE P200000638 A EEP200000638 A EE P200000638A EE 200000638 A EE200000638 A EE 200000638A
Authority
EE
Estonia
Prior art keywords
chloronaphth
ylsulfonyl
piperazine
pyridyl
benzoyl
Prior art date
Application number
EEP200000638A
Other languages
English (en)
Estonian (et)
Inventor
Ashford Marianne
James Roger
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000638A publication Critical patent/EE200000638A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
EEP200000638A 1998-05-02 1999-04-27 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm EE200000638A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (1)

Publication Number Publication Date
EE200000638A true EE200000638A (et) 2002-04-15

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000638A EE200000638A (et) 1998-05-02 1999-04-27 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm

Country Status (16)

Country Link
EP (1) EP1084118A1 (no)
JP (1) JP2002513789A (no)
KR (1) KR20010043216A (no)
CN (1) CN1308629A (no)
AU (1) AU3719699A (no)
BR (1) BR9910176A (no)
CA (1) CA2331041A1 (no)
EE (1) EE200000638A (no)
GB (1) GB9809350D0 (no)
HU (1) HUP0102394A3 (no)
IL (1) IL139405A0 (no)
NO (1) NO20005498D0 (no)
PL (1) PL343705A1 (no)
SK (1) SK16522000A3 (no)
WO (1) WO1999057112A1 (no)
ZA (1) ZA200006036B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID23991A (id) 1997-09-30 2000-06-14 Daiichi Seiyaku Co Turunan-turunan sulfonil
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
AU7453498A (en) * 1997-05-30 1998-12-30 Takeda Chemical Industries Ltd. Sulfonamide derivatives, their production and use
ID23991A (id) * 1997-09-30 2000-06-14 Daiichi Seiyaku Co Turunan-turunan sulfonil

Also Published As

Publication number Publication date
ZA200006036B (en) 2002-01-25
HUP0102394A3 (en) 2003-01-28
JP2002513789A (ja) 2002-05-14
BR9910176A (pt) 2001-01-09
HUP0102394A2 (hu) 2001-12-28
WO1999057112A1 (en) 1999-11-11
CA2331041A1 (en) 1999-11-11
NO20005498L (no) 2000-11-01
GB9809350D0 (en) 1998-07-01
IL139405A0 (en) 2001-11-25
NO20005498D0 (no) 2000-11-01
EP1084118A1 (en) 2001-03-21
PL343705A1 (en) 2001-08-27
SK16522000A3 (sk) 2001-05-10
AU3719699A (en) 1999-11-23
CN1308629A (zh) 2001-08-15
KR20010043216A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
DE60125980D1 (de) P38kinase-inhibitoren vom piperidin/piperazin-typ
NO20015746D0 (no) Ny anvendelse av 1-[4-(5-cyanindol-3-yl)butyl]-4-(2- karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptablesalter
DE60044004D1 (de) Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren
EE200400019A (et) 1-[4-(5-tsüanoindool-3-üül)butüül]-4-(2-karbamoüülbensofuraan-5-üül)piperasiinvesin ikkloriidi polümorfsed vormid
SE8207425D0 (sv) 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl)butyl)-1-piperazinyl)pyrimidiner
NO20023319L (no) Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen
DE60036539D1 (de) Verwendung von ungenutzter Speicherkapazität bei vernetzten Computern
CY1109347T1 (el) Συνδυασμος που αποτελειται απο εναν αναστολεα μεταλλαγης σηματος και ενα παραγωγο εποθιλονης
EE200000638A (et) 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm
ATE553097T1 (de) Piperidin- und piperazin-substituierte n- hydroxyformamiden zur verwendung als metalloproteinaseinhibitoren
ATE269857T1 (de) 4-phenyl-1-piperazinyl, -piperidinyl und - tetrahydropyridyl-derivate
DE60105746D1 (de) 2-(4-Pyridinyl)-Benzofurane zur Verwendung als Metalloprotease-Inhibitoren
NO20023951L (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
ID26146A (id) Proses untuk cis-1-{2-[4-(6-metoksi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il]fenoksi]etil} pirolidin
DE50304858D1 (de) N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetemid-und entsprechende piperidinderivate als faktor xa inhibitoren zur behandlung von thromboembolischen erkrankungen
RS49904B (sr) Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida
AU2003244922A1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
IL157061A (en) Process and intermediates for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl)piperazin -1-yl)-methanone and salts thereof
HK1062683A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(E)-=-methyloxime and its salts.
AU2000246280A1 (en) Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols
NO20030658L (no) Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteiner
WO2005113526A3 (en) Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
NO905511D0 (no) Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon.
HUP0202967A3 (en) Novel 1-[1-(hetero)-aril-1-perhydroxy-alkyl-methyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
SI1436282T1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts